NASDAQ:KALA | Free Cash Flow | KALA BIO, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.9M
2025-12-31-$4.56M
2025-06-30-$16.56M
2025-03-31-$8.82M
2024-12-31-$4.6M
2024-03-31-$10.84M
2023-12-31-$7.7M
2023-03-31-$9.68M
2022-12-31-$13.74M
2022-03-31-$24.09M
2021-12-31-$27.9M
2021-03-31-$32.64M
2020-12-31-$25.92M
2020-03-31-$19.88M$292,000.00-$20.17M
2019-12-31-$18.21M$188,000.00-$18.4M
2019-03-31-$31.17M$444,000.00-$31.61M
2018-12-31-$15.99M$910,000.00-$16.9M
2018-03-31-$12.71M$373,000.00-$13.09M
2017-12-31-$6.56M$282,000.00-$6.85M
2017-03-31-$9.36M$72,000.00-$9.43M
2016-12-31-$7.33M$58,000.00-$7.39M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$31.99M
2024-12-31-$29.38M
2023-12-31-$27.93M
2022-12-31-$78.91M
2021-12-31-$108.24M
2020-12-31-$90.69M
2019-12-31-$92.72M$1.34M-$94.06M
2018-12-31-$54.12M$1.58M-$55.7M
2017-12-31-$34.1M$480,000.00-$34.58M
2016-12-31-$27.35M$153,000.00-$27.5M
2015-12-31-$15.09M$252,000.00-$15.34M